Pfizer Europe MA EEIG
- J01 - Antibacterianos para uso sistémico
- TYGACIL powder for solution for infusion 50 mg
- J02 - Antimicóticos de uso sistémico
- VFEND film-coated tablet 200 mg
- VFEND film-coated tablet 50 mg
- J07 - Vacunas
- TRUMENBA PREFILLED SYRINGE suspension for injection
- L01 - Antineoplásicos
- TOPOTECAN HOSPIRA concentrate for solution for infusion 4 mg/4 ml
- TORISEL concentrate for solution for infusion 30 mg
- TRAZIMERA powder for solution for infusion 150 mg
- TRAZIMERA powder for solution for infusion 420 mg
- VIZIMPRO film-coated tablet 15 mg
- VIZIMPRO film-coated tablet 30 mg
- XALKORI capsule, hard 200 mg
- XALKORI capsule, hard 250 mg
- ZIRABEV concentrate for solution for infusion 100 mg/4 ml
- ZIRABEV concentrate for solution for infusion 400 mg/16 ml
- L04 - Inmunosupresores
- XELJANZ film-coated tablet 10 mg
- XELJANZ film-coated tablet 5 mg
- M05 - Preparados para el tratamiento de enfermedades óseas
- ZOLEDRONIC ACID HOSPIRA concentrate for solution for infusion 4 mg/5 ml
- ZOLEDRONIC ACID HOSPIRA solution for infusion 4 mg/100 ml
- N07 - Otros fármacos activos sobre el sistema nervioso
- VYNDAQEL capsule, soft 20 mg